The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.

Investigators from @hopkinskimmel (@wonjinho1, @DNSidiropoulos, @AmandaHuffPhD, @DrLizJaffee) create free atlas of ...

The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.

Zenas BioPharma, Inc. provided an update on its clinical programs and financial results for the first quarter of 2025. The Company anticipates topline results from its pivotal Phase 3 INDIGO trial for ...

Cabaletta Bio, Inc. announced promising results from its ongoing RESET clinical trials for its investigational therapy rese-cel, focusing on autoimmune diseases. In the trials, notable outcomes ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

Flywheel, the leading medical imaging data management and analysis platform, today announced key milestones achieved in 2025. The company also recently closed on an oversubscribed $25 million ...

Forbes contributors publish independent expert analyses and insights. Tor Constantino is an ex-reporter, turned AI consultant & tech writer. Parexel's research found 6% of surveyed executives say ...

The data was revealed as a UK delegation headed by MHRA chief executive Lawrence Tallon attended the J PM Healthcare ...

A new partnership to promote Swedish clinical trials has been launched, but concerns remain about a lack of patient voices ...